Download Files:
Products Details
Product Description
– BTK-IN-14 is a potent inhibitor of BTK. BTK plays an important role in signaling mediated by B cell antigen receptor (BCR) and Fcγreceptor (FcγR) in B cells and myeloid cells, respectively. BTK-IN-14 has the potential for the research of related diseases, especially autoimmune diseases, inflammatory diseases or cancer (extracted from patent WO2022057894A1, compound 1)[1].
Web ID
– HY-147584
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C38H44N8O4
References
– [1] Guangxiu Dai, et al. Heteroaryl heterocyclic compounds and uses thereof. Patent WO2022057894A1.
CAS Number
– 2764674-60-2
Molecular Weight
– 676.81
SMILES
– C[C@H]1CN(C[C@@H](N1C2=CC=C(N=C2)NC3=CC(C4=CC=NC(N5C=CN6C(C5=O)=CC7=C6CC(C)(C7)C)=C4CO)=CN(C3=O)C)C)C8COC8
Clinical Information
– No Development Reported
Research Area
– Cancer; Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– Btk
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
